CRISIL Limited (CRISIL.BO)
INR 5804.55
(-1.07%)
INR 5804.55
(-1.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 7.88 Billion | 4.56 Billion | 4.03 Billion | 5 Billion | 4.45 Billion | 3.78 Billion |
| Net Income | 6.58 Billion | 7.42 Billion | 6.18 Billion | 4.58 Billion | 4.91 Billion | 4.99 Billion |
| Depreciation & Amortization | 1.03 Billion | 1.03 Billion | 1.05 Billion | 1.21 Billion | 368.6 Million | 428.2 Million |
| Deferred income taxes | -1.64 Billion | -2.79 Billion | -2.66 Billion | -1.46 Billion | -1.68 Billion | -1.54 Billion |
| Stock-based compensation | 100 Thousand | 200 Thousand | 15.7 Million | 24.8 Million | 81.4 Million | 187.6 Million |
| Change in working capital | 1.24 Billion | -1.12 Billion | -535.3 Million | 569.6 Million | 835.1 Million | -234 Million |
| Other non-cash items | 659.4 Million | 21.7 Million | -27.2 Million | 79.8 Million | -54.3 Million | -44.5 Million |
| Investing Cash Flow | -3.35 Billion | -616.4 Million | -882.5 Million | -3.22 Billion | -709.7 Million | -718.1 Million |
| Investments in PPE | -629.5 Million | -411.4 Million | -227.9 Million | -349.2 Million | -290.6 Million | -334.7 Million |
| Acquisitions | -289.09 Million | 22.5 Million | 497.9 Million | -2.51 Billion | 13.8 Million | -560 Million |
| Investment purchases | -2.49 Billion | -267.8 Million | -1.3 Billion | -438.6 Million | -558.7 Million | -392.3 Million |
| Sales/Maturities of investments | 59.2 Million | 11.7 Million | 500 Thousand | 70.6 Million | 129.1 Million | 398.6 Million |
| Other Investing Activities | -1.00 | 28.6 Million | 148.9 Million | 300 Thousand | -3.3 Million | 170.3 Million |
| Financing Cash Flow | -4.07 Billion | -3.68 Billion | -2.91 Billion | -2.65 Billion | -2.28 Billion | -2.03 Billion |
| Debt repayment | -550.6 Million | -542.9 Million | -582.3 Million | -900 Thousand | -400 Thousand | -5.5 Million |
| Dividends payments | -3.58 Billion | -3.43 Billion | -2.76 Billion | -2.32 Billion | -2.51 Billion | -2.51 Billion |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 92 Million | 354.7 Million | 414.6 Million | 352.2 Million | 229.5 Million | 499.5 Million |
| Other Financing Activities | -587.2 Million | -606.5 Million | -560 Million | -682 Million | -2.3 Million | -12.6 Million |
| Accounts receivables | 431.5 Million | -2.17 Billion | -910.7 Million | -495.9 Million | 919.5 Million | -583.1 Million |
| Accounts payables | 1.7 Million | 112 Million | 421.1 Million | 153.3 Million | 111.3 Million | 67.2 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 815.5 Million | 938.9 Million | -45.7 Million | 912.2 Million | -195.7 Million | 281.9 Million |
| Cash at beginning of period | 3.19 Billion | 2.89 Billion | 2.74 Billion | 3.39 Billion | 1.99 Billion | 886.9 Million |
| Cash at end of period | 3.69 Billion | 3.19 Billion | 2.89 Billion | 2.74 Billion | 3.39 Billion | 1.99 Billion |
| Capital Expenditure | -629.5 Million | -411.4 Million | -227.9 Million | -349.2 Million | -290.6 Million | -334.7 Million |
| Effect of forex changes on cash | -32.4 Million | 29.5 Million | -88 Million | -20.4 Million | -63.3 Million | 27.1 Million |
| Net cash flow / Change in cash | 499.2 Million | 293.3 Million | 150.4 Million | -642.3 Million | 1.39 Billion | 1.1 Billion |
| Free Cash Flow | 7.25 Billion | 4.15 Billion | 3.8 Billion | 4.65 Billion | 4.16 Billion | 3.45 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.5 Billion | 1.37 Billion | 6.58 Billion | 2.1 Billion | 1.51 Billion | 1.5 Billion |
| Depreciation & Amortization | - | - | 1.03 Billion | 252.1 Million | 265 Million | 260.7 Million |
| Deferred income taxes | - | - | -1.64 Billion | - | - | - |
| Stock-based compensation | - | - | 100 Thousand | 100 Thousand | - | - |
| Change in working capital | - | - | 1.24 Billion | - | - | - |
| Other non-cash items | -1.5 Billion | -1.37 Billion | 659.4 Million | -2.1 Billion | -1.51 Billion | -1.5 Billion |
| Investing Cash Flow | - | - | -3.35 Billion | - | - | - |
| Investments in PPE | - | - | -629.5 Million | - | - | - |
| Acquisitions | - | - | -289.09 Million | - | - | - |
| Investment purchases | - | - | -2.49 Billion | - | - | - |
| Sales/Maturities of investments | - | - | 59.2 Million | - | - | - |
| Other Investing Activities | - | - | -1.00 | - | - | - |
| Financing Cash Flow | - | - | -4.07 Billion | - | - | - |
| Debt repayment | - | - | -550.6 Million | - | - | - |
| Dividends payments | - | - | -3.58 Billion | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 92 Million | - | - | - |
| Other Financing Activities | - | - | -587.2 Million | - | - | - |
| Accounts receivables | - | - | 431.5 Million | - | - | - |
| Accounts payables | - | - | 1.7 Million | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | 815.5 Million | - | - | - |
| Cash at beginning of period | - | - | 3.19 Billion | 3.19 Billion | 1.94 Billion | 441.9 Million |
| Cash at end of period | - | - | 3.69 Billion | 3.69 Billion | 1.51 Billion | 1.94 Billion |
| Capital Expenditure | - | - | -629.5 Million | - | - | - |
| Effect of forex changes on cash | - | - | -32.4 Million | - | - | - |
| Net cash flow / Change in cash | - | - | 499.2 Million | 504.2 Million | -427.8 Million | 1.5 Billion |
| Free Cash Flow | - | - | 7.25 Billion | 504.2 Million | 1.51 Billion | 1.5 Billion |
SUPERHOUSE
MPFRY
300253
RGRNF
CONCORDBIO
RAMCOSYS